GILEAD SCIENCES, INC. — Director's Dealing 2015

Jun 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-06-26

Reporting Person: Cogan John Francis (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-26	Common Stock	M	12000	$14.3400	Acquired	56309	Direct
2015-06-26	Common Stock	M	15000	$20.705	Disposed	71309	Direct
2015-06-26	Common Stock	S	27000	$120.1267	Disposed	44309	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-26	Non-Qualified Stock Option (Right to Buy)	$14.3400	M	12000	Disposed	2016-01-26	Common Stock (12000)	Direct
2015-06-26	Non-Qualified Stock Option (Right to Buy)	$20.705	M	15000	Disposed	2017-05-09	Common Stock (15000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Options are 100% vested on the date of grant.

F3: Sale prices reported for the transactions reported here range from $120.00 to $120.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.